A Study of Intravesical Apaziquone as a Surgical Adjuvant in Participant Undergoing Transurethral Resection Bladder Tumor (TURBT)
Clinical trial NCT02563561 · TERMINATED
Trial details
- NCT number
- NCT02563561
- Sponsor
- Spectrum Pharmaceuticals, Inc
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-10-09
- Primary completion
- 2017-03-10
- Enrollment
- 62
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.